Anzeige
Meldung des Tages: Freitagabend nachbörslich veröffentlicht – was der Markt erst am Montag sieht

Fresenius Medical Care Aktie (ADR) News

Aktie
WKN:  879529 ISIN:  US3580291066 US-Symbol:  FMS Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  Deutschland
19,00 €
+0,00 €
0,00%
09:51:36 Uhr
Depot/Watchlist
Marktkapitalisierung *
12,02 Mrd. €
Streubesitz
91,95%
KGV
-
Dividende
0,63 $
Dividendenrendite
2,88%
Faktor
2
Originalaktie
DE0005785802

Fresenius Medical Care Aktie (ADR) News

09.01.26 - PR Newswire
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned PR Newswire
10.12.25 - PR Newswire
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
Fresenius Medical Care appoints Charles Hugh-​Jones as Global Chief Medical Officer and member of the Management Board PR Newswire
04.11.25 - PR Newswire
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter ...
30.10.25 - PR Newswire
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
Fresenius Medical Care highlights real-​world advances in hemodiafiltration and AI at ASN Kidney Week 2025 PR Newswire
01.10.25 - PR Newswire
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement PR Newswire
18.09.25 - PR Newswire
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-​Based Care asset and appointing a new leader for the operating segment PR ...
11.08.25 - PR Newswire
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework PR Newswire
05.08.25 - PR Newswire
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
Fresenius Medical Care delivers strong organic revenue growth and double-​digit operating income growth in the second quarter of 2025 PR Newswire
31.07.25 - PR Newswire
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
Fresenius Medical Care's Third-​Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-​Driven, Precision Kidney Disease Care PR ...
03.07.25 - PR Newswire
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico PR Newswire
17.06.25 - PR Newswire
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation PR ...
12.06.25 - PR Newswire
Focus Graphite Achieves 5N Purity from Lac Knife Graphite, Refined to Nuclear-Grade Purity Levels in AETC Testing
Focus Graphite Achieves 5N Purity from Lac Knife Graphite, Refined to Nuclear-​Grade Purity Levels in AETC Testing PR Newswire
04.06.25 - PR Newswire
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-​Volume Hemodiafiltration Dialysis ...
30.05.25 - PR Newswire
Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025
Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025 PR Newswire
22.05.25 - PR Newswire
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History PR Newswire
06.05.25 - PR Newswire
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
Fresenius Medical Care starts 2025 with strong organic revenue and income growth PR Newswire
13.03.25 - PR Newswire
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum PR Newswire
25.02.25 - PR Newswire
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 PR Newswire
24.02.25 - PR Newswire
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics PR Newswire

Newssuche

Videos

newspaper
29.01.26 -10,12%
Rekordjagd bei Gold! Februar Ausblick & Forecast
Ab 2.2. (Montag) börsentäglich um 18 Uhr FEIERABEND-​TRADING. Echte Trades, strategiebasiert, ... Mehr »